Success Metrics

Clinical Success Rate
100.0%

Based on 14 completed trials

Completion Rate
100%(14/14)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
4
21%
Ph early_phase_1
1
5%
Ph not_applicable
5
26%
Ph phase_1
2
11%
Ph phase_2
3
16%
Ph phase_3
4
21%

Phase Distribution

3

Early Stage

3

Mid Stage

8

Late Stage

Phase Distribution19 total trials
Early Phase 1First-in-human
1(5.3%)
Phase 1Safety & dosage
2(10.5%)
Phase 2Efficacy & side effects
3(15.8%)
Phase 3Large-scale testing
4(21.1%)
Phase 4Post-market surveillance
4(21.1%)
N/ANon-phased studies
5(26.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.3%

14 of 15 finished

Non-Completion Rate

6.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

19

all time

Status Distribution
Completed(14)
Terminated(1)
Other(4)

Detailed Status

Completed14
unknown4
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (5.3%)
Phase 12 (10.5%)
Phase 23 (15.8%)
Phase 34 (21.1%)
Phase 44 (21.1%)
N/A5 (26.3%)

Trials by Status

unknown421%
completed1474%
withdrawn15%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT07216729Not Applicable

The Effects of Probiotic Supplementation on State and Trait Stress, Anxiety, and Depression Symptoms in Stressed Adults

Completed
NCT02865564Not Applicable

Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics

Completed
NCT00893711Not Applicable

Lactobacillus Reuteri Versus Placebo in the Treatment and Prevention of Infantile Colic

Unknown
NCT02765217Phase 4

Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children

Completed
NCT04541771Phase 2

The Role of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants

Unknown
NCT00789464Phase 2

Probiotics for Girls With Recurring Urinary Tract Infections

Withdrawn
NCT01620125Early Phase 1

Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes Patients

Completed
NCT02989350Not Applicable

Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children

Completed
NCT03117322Phase 4

Synbiotic, Prebiotics and Probiotics in Children With Cerebral Palsy and Constipation

Completed
NCT02871908Phase 4

Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial

Completed
NCT01899378Phase 1

Safety and Efficacy of Probiotics in Bangladeshi Infants

Completed
NCT02577133Phase 2

Prevention of Colic With the Probiotic Lactobacillus Reuteri

Unknown
NCT01968408Phase 3

Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children

Completed
NCT01542320Not Applicable

Effect of Probiotic Supplementation on Immune Function in Healthy Infants

Completed
NCT01837940Phase 3

Efficacy of a Dietary Supplementation With Lactobacillus Reuteri for Digestive Health in an Elderly Population

Completed
NCT01568567Phase 1

Study to Demonstrate the Safety of a Novel Powder Formulation of Lactobacilli in Adults

Completed
NCT01046617Phase 3

Lactobacillus Reuteri for the Treatment of Infantile Colic:

Completed
NCT01388712Phase 4

Lactobacillus Reuteri in Children With Constipation

Unknown
NCT01046656Phase 3

L Reuteri for the Prevention of Nosocomial Diarrhea

Completed

All 19 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
19